Razavi International Journal of Medicine

Published by: Kowsar

Personalized Cancer Medicine: a Future Direction of Personal Genomics

Ehsan Ghayoor Karimiani 1 , *
Author Information
1 Department of Medical Genetics, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Razavi International Journal of Medicine: November 01, 2013, 1 (1); 3-4
  • Published Online: November 30, 2013
  • Article Type: Editorial
  • Received: September 26, 2013
  • Accepted: October 9, 2013
  • DOI: 10.17795/rijm14955

To Cite: Ghayoor Karimiani E. Personalized Cancer Medicine: a Future Direction of Personal Genomics, Razavi Int J Med. 2013 ; 1(1):3-4. doi: 10.17795/rijm14955.

Copyright © 2013, Razavi Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Personalized Medicine and Molecular Genetic Diagnostics
2. Molecular Cancer Medicine in Healthcare
3. Concluding Remarks
  • 1. Schilsky RL. Personalized medicine in oncology: the future is now. Nat Rev Drug Discov. 2010; 9(5): 363-6[DOI][PubMed]
  • 2. Karimiani EG, Day P. Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells. Integr Biol (Camb). 2013; 5(5): 759-67[DOI][PubMed]
  • 3. Esmaeili B, Rezaee SA, Layegh P, Tavakkol Afshari J, Dye P, Ghayoor Karimiani E, et al. Expression of IL-17 and COX2 gene in peripheral blood leukocytes of vitiligo patients. Iran J Allergy Asthma Immunol. 2011; 10(2): 81-9[PubMed]
  • 4. Rosenblum D, Peer D. Omics-based nanomedicine: The future of personalized oncology. Cancer Lett. 2013; [DOI][PubMed]
  • 5. Natrajan R, Mackay A, Lambros MB, Weigelt B, Wilkerson PM, Manie E, et al. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. J Pathol. 2012; 227(1): 29-41[DOI][PubMed]
  • 6. Sandison HE, Usher S, Karimiani EG, Ashton G, Menasce LP, Radford JA, et al. PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome. J Clin Pathol. 2013; 66(9): 764-7[DOI][PubMed]
  • 7. Verma M, Karimiani EG, Byers RJ, Rehman S, Westerhoff HV, Day PJ. Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. Integr Biol (Camb). 2013; 5(3): 543-54[DOI][PubMed]
  • 8. Leary RJ, Sausen M, Diaz LA, Jr, Velculescu VE. Cancer detection using whole-genome sequencing of cell free DNA. Oncotarget. 2013; 4(8): 1119-20[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments